Ianalumab in Sjögren's syndrome: what can we learn from lupus trials?
- PMID: 36088945
- DOI: 10.1016/S0140-6736(22)01536-7
Ianalumab in Sjögren's syndrome: what can we learn from lupus trials?
Comment in
-
Ianalumab in Sjögren's syndrome: what can we learn from lupus trials? - Authors' reply.Lancet. 2022 Sep 10;400(10355):808-809. doi: 10.1016/S0140-6736(22)01538-0. Lancet. 2022. PMID: 36088946 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
